Most Read Articles
Roshini Claire Anthony, 6 days ago

For coffee drinkers, drinking filtered coffee may be tied to a lower mortality risk, including cardiovascular disease (CVD)-related mortality, a study from Norway suggested.

3 days ago
Use of corticosteroid is not associated with improved outcomes in idiopathic pulmonary fibrosis (IPF) patients admitted to the hospital with acute exacerbation (AE), reveals a recent study. In addition, corticosteroids may even contribute to reduced overall survival following exacerbation.
Dr. Wong Soon Tee, 28 May 2020
Acne is a common skin problem seen in primary care. Dr Wong Soon Tee of Assurance Skin Clinic at Mt Elizabeth Novena Hospital, Singapore shares his insights with Pearl Toh on how to manage acne in the primary care setting.
27 May 2020
The perception that proton pump inhibitors (PPIs) cause multiple serious adverse effects (AEs) is supported by many internists, who then recommend treatment cessation even in patients at high risk for upper gastrointestinal bleeding (UGIB), reveals a study.

Medication nonadherence may lead to treatment escalation in children with UC

03 Nov 2019

In paediatric patients with ulcerative colitis (UC), nonadherence to mesalazine negatively affects its therapeutic efficacy and may, in turn, result in treatment escalation, according to data from PROTECT.

PROTECT included 268 newly diagnosed paediatric UC patients (mean age, 12.3 years; 50 percent female). All patients received standardized mesalazine, with pre‐established criteria for escalation to thiopurines or anti‐tumour necrosis factor alpha (TNFα inhibitors). Adherence was monitored using pill bottles with electronic caps.

Researchers examined whether longitudinal adherence to treatment was associated with steroid‐free remission at week 52 (defined as quiescent disease on mesalazine alone with no corticosteroids ≥4 weeks prior) and need for treatment escalation (defined as introduction of immunomodulators, calcineurin‐inhibitors or anti‐TNFα inhibitors).

Results revealed that average mesalazine adherence trajectories were not predictive of steroid‐free remission at week 52. On the other hand, declining adherence over time (adherence rate of ≤85.7 percent at month 6) showed a strong association with treatment escalation (p=0.001).

According to the researchers, the present data highlight the importance of targeting adherence difficulties early in the disease course to reduce the likelihood of the need for treatment escalation in this population. They also stressed that treatment escalation is not based on suboptimal adherence to maintenance medication, but rather on disease response (or lack of response) to maintenance medication.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Gastroenterology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 6 days ago

For coffee drinkers, drinking filtered coffee may be tied to a lower mortality risk, including cardiovascular disease (CVD)-related mortality, a study from Norway suggested.

3 days ago
Use of corticosteroid is not associated with improved outcomes in idiopathic pulmonary fibrosis (IPF) patients admitted to the hospital with acute exacerbation (AE), reveals a recent study. In addition, corticosteroids may even contribute to reduced overall survival following exacerbation.
Dr. Wong Soon Tee, 28 May 2020
Acne is a common skin problem seen in primary care. Dr Wong Soon Tee of Assurance Skin Clinic at Mt Elizabeth Novena Hospital, Singapore shares his insights with Pearl Toh on how to manage acne in the primary care setting.
27 May 2020
The perception that proton pump inhibitors (PPIs) cause multiple serious adverse effects (AEs) is supported by many internists, who then recommend treatment cessation even in patients at high risk for upper gastrointestinal bleeding (UGIB), reveals a study.